Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Meisel

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|May 28, 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study GroupHerbert Pichler, Petr Sedlacek, Roland Meisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in LeukemiaEva Rettinger, Dirk Heckl, Martin Hutter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Blood|November 9, 2006
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantationRoland Meisel, Lisa Kuypers, Uta Dirksen, et al.
Haematologica|December 17, 2016
Human RAD52 - a novel player in DNA repair in cancer and immunodeficiencySujal Ghosh, Andrea Hönscheid, Gregor Dückers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2016
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 AntibodyUrsula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.
Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|May 28, 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study GroupHerbert Pichler, Petr Sedlacek, Roland Meisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in LeukemiaEva Rettinger, Dirk Heckl, Martin Hutter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Blood|November 9, 2006
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantationRoland Meisel, Lisa Kuypers, Uta Dirksen, et al.
Haematologica|December 17, 2016
Human RAD52 - a novel player in DNA repair in cancer and immunodeficiencySujal Ghosh, Andrea Hönscheid, Gregor Dückers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2016
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 AntibodyUrsula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.
Haematologica|February 15, 2024
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adultsTobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Pageof 13